Stock analysts at JPMorgan Chase & Co. initiated coverage on shares of athenahealth (NASDAQ:ATHN) in a research report issued on Tuesday, AnalystRatingsNetwork.com reports. The brokerage set an “overweight” rating and a $170.00 price targeton the stock. JPMorgan Chase & Co.’s price target would suggest a potential upside of 7.77% from the stock’s previous close.
In other athenahealth news, COO Ed Park sold 1,500 shares of athenahealth stock in atransaction on Wednesday, September 2nd. The stock was sold at an average price of $129.64, for a total transaction of $194,460.00. Following the completion of the sale, the chief operating officer now directly owns 34,933 shares of the company’s
stock, valued at approximately $4,528,714.12. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jonathan Bush sold 20,000 shares of athenahealth stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $157.50, for a total value of $3,150,000.00. Following the sale, the chief executive officer now directly owns 311,234 shares of the company’s stock, valued at $49,019,355. The disclosure for this sale can be found here.
Shares of athenahealth (NASDAQ:ATHN) traded up 1.17% during midday trading on Tuesday, reaching $157.74. 388,480 shares of the company’s stock were exchanged. athenahealth has a 12 month low of $110.68 and a 12 month high of $168.59. The firm has a 50 day moving average price of $148.11 and a 200 day moving average price of $131.32. The company has a market cap of $6.12 billion and a P/E ratio of 411.85.
athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, October 22nd. The company reported $0.36 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.10. During the same quarter in the prior year, the firm posted $0.27 earnings per share. The firm earned $236.10 million during the quarter, compared to the consensus estimate of $233.03 million. The company’s revenue was up 24.0% on a year-over-year basis. Equities research analysts forecast that athenahealth will post $1.32 earnings per share for the current fiscal year.
